LING YI MEI: Open Payments
NPI 1194358028 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 14 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $521 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $89 |
| ABBVIE INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| 180 Medical, Inc. | 2 | $37 |
| UROGEN PHARMA, INC. | 1 | $36 |
| Tempus AI, Inc | 1 | $32 |
| TOLMAR, INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Endo USA, Inc. | 1 | $17 |
Products named: ERLEADA, KEYTRUDA, XT CDX, LUPRON DEPOT, BOTOX, JATENZO, LYNPARZA, XIAFLEX.
Industry payments across NY — which companies pay providers there.
